News Related to Gastroparesis

Related coverage linked through entity extraction aliases.

GLP-1 Weight Loss Drugs Linked to Scurvy Risk, Veterinary Research Expands to Cats

Mar 06, 2026

New research links GLP-1 drugs like Ozempic to increased scurvy risk through appetite suppression and poor nutrition. University of Florida researchers are testing a GLP-1 implant for obese cats as feline obesity affects nearly 60% of US cats.

FDA Approves Tradipitant for Motion Sickness, First New Treatment in Over 40 Years

Nov 28, 2025

The FDA approved tradipitant (Nereus), an oral NK-1 receptor antagonist, for prevention of motion-induced vomiting on December 30, 2025. The approval marks the first new pharmacologic treatment for motion sickness in over four decades.